Role of microRNAs in herpesvirus latency and persistence

Journal of General Virology

Volumn 96, Issue 4, 2015, Pages 739-751

  Grey, Finn ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 155; VIRUS PROTEIN; VIRUS RNA;

ANTIGEN RECOGNITION; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR IMMUNITY; EPITHELIAL MESENCHYMAL TRANSITION; GENE CONTROL; GENE EXPRESSION REGULATION; GENETIC CONSERVATION; HERPES VIRUS INFECTION; HERPESVIRIDAE; IMMUNE EVASION; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE HOMOLOGY; VIRUS GENE; VIRUS GENOME; VIRUS LATENCY; VIRUS REACTIVATION; VIRUS REPLICATION; VIRUS TRANSCRIPTION; ANIMAL; GENETICS; HUMAN; PHYSIOLOGY;

HERPESVIRIDAE;

ANIMALS; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRIDAE; HUMANS; MICRORNAS; RNA, VIRAL; VIRUS LATENCY;

EID: 84924943081     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.070862-0     Document Type: Article

References (99)

1. Abend, J. R., Uldrick, T. & Ziegelbauer, J. M. (2010). Regulation of tumor necrosis factor-like weak inducer of apoptosis receptor protein (TWEAKR) expression by Kaposi’s sarcoma-associated herpesvirus microRNA prevents TWEAK-induced apoptosis and inflammatory cytokine expression. J Virol 84, 12139–12151.
2. Abend, J. R., Ramalingam, D., Kieffer-Kwon, P., Uldrick, T. S., Yarchoan, R. & Ziegelbauer, J. M. (2012). Kaposi’s sarcoma-associated herpesvirus microRNAs target IRAK1 and MYD88, two components of the toll-like receptor/interleukin-1R signaling cascade, to reduce inflammatory-cytokine expression. J Virol 86, 11663–11674.
3. Bartel, D. P. (2009). MicroRNAs: target recognition and regulatory functions. Cell 136, 215–233.
4. Bellare, P. & Ganem, D. (2009). Regulation of KSHV lytic switch protein expression by a virus-encoded microRNA: an evolutionary adaptation that fine-tunes lytic reactivation. Cell Host Microbe 6, 570–575.
5. Blaskovic, D., Stanceková, M., Svobodová, J. & Mistríková J. (1980). Isolation of five strains of herpesviruses from two species of free living small rodents. Acta Virol 24, 468.
6. Bogerd, H. P., Skalsky, R. L., Kennedy, E. M., Furuse, Y., Whisnant, A. W., Flores, O., Schultz, K. L., Putnam, N., Barrows, N. J. & other authors (2014). Replication of many human viruses is refractory to inhibition by endogenous cellular microRNAs. J Virol 88, 8065–8076.
7. Boss, I. W., Nadeau, P. E., Abbott, J. R., Yang, Y., Mergia, A. & Renne, R. (2011). A Kaposi’s sarcoma-associated herpesvirus-encoded ortholog of microRNA miR-155 induces human splenic B-cell expansion in NOD/LtSz-scid IL2Rcnull mice. J Virol 85, 9877–9886.
8. Buck, A. H., Santoyo-Lopez, J., Robertson, K. A., Kumar, D. S., Reczko, M. & Ghazal, P. (2007). Discrete clusters of virus-encoded microRNAs are associated with complementary strands of the genome and the 7.2-kilobase stable intron in murine cytomegalovirus. J Virol 81, 13761–13770.
9. Cai, X., Lu, S., Zhang, Z., Gonzalez, C. M., Damania, B. & Cullen, B. R. (2005). Kaposi’s sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells. Proc Natl Acad Sci U S A 102, 5570–5575.
10. Cazalla, D., Yario, T. & Steitz, J. A. (2010). Down-regulation of a host microRNA by a Herpesvirus saimiri noncoding RNA. Science 328, 1563–1566.
11. Choy, E. Y., Siu, K. L., Kok, K. H., Lung, R. W., Tsang, C. M., To, K. F., Kwong, D. L., Tsao, S. W. & Jin, D. Y. (2008). An Epstein–Barr virus-encoded microRNA targets PUMA to promote host cell survival. J Exp Med 205, 2551–2560.
12. Cosmopoulos, K., Pegtel, M., Hawkins, J., Moffett, H., Novina, C., Middeldorp, J. & Thorley-Lawson, D. A. (2009). Comprehensive profiling of Epstein–Barr virus microRNAs in nasopharyngeal carcinoma. J Virol 83, 2357–2367.
13. Costinean, S., Zanesi, N., Pekarsky, Y., Tili, E., Volinia, S., Heerema, N. & Croce, C. M. (2006). Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in Em-miR155 transgenic mice. Proc Natl Acad Sci U S A 103, 7024–7029.
14. Dölken, L., Malterer, G., Erhard, F., Kothe, S., Friedel, C. C., Suffert, G., Marcinowski, L., Motsch, N., Barth, S. & Beitzinger, M. (2010). Systematic analysis of viral and cellular microRNA targets in cells latently infected with human gamma-herpesviruses by RISC immuno-precipitation assay. Cell Host Microbe 7, 324–334.
15. Ebert, M. S. & Sharp, P. A. (2012). Roles for microRNAs in conferring robustness to biological processes. Cell 149, 515–524.
16. Eis, P. S., Tam, W., Sun, L., Chadburn, A., Li, Z., Gomez, M. F., Lund, E. & Dahlberg, J. E. (2005). Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci U S A 102, 3627–3632.
17. Ellis, A. L., Wang, Z., Yu, X. & Mertz, J. E. (2010). Either ZEB1 or ZEB2/SIP1 can play a central role in regulating the Epstein–Barr virus latent-lytic switch in a cell-type-specific manner. J Virol 84, 6139–6152.
18. Ellis-Connell, A. L., Iempridee, T., Xu, I. & Mertz, J. E. (2010). Cellular microRNAs 200b and 429 regulate the Epstein–Barr virus switch between latency and lytic replication. J Virol 84, 10329–10343.
19. Feederle, R., Linnstaedt, S. D., Bannert, H., Lips, H., Bencun, M., Cullen, B. R. & Delecluse, H. J. (2011). A viral microRNA cluster strongly potentiates the transforming properties of a human herpesvirus. PLoS Pathog 7, e1001294.
20. Feldman, E. R., Kara, M., Coleman, C. B., Grau, K. R., Oko, L. M., Krueger, B. J., Renne, R., van Dyk, L. F. & Tibbetts, S. A. (2014). Virus-encoded microRNAs facilitate gammaherpesvirus latency and pathogenesis in vivo. MBio 5, e00981-14.
21. Feng, P., Moses, A. & Früh, K. (2013). Evasion of adaptive and innate immune response mechanisms by c-herpesviruses. Curr Opin Virol 3, 285–295.
22. Frappier, L. (2012). EBNA1 and host factors in Epstein–Barr virus latent DNA replication. Curr Opin Virol 2, 733–739.
23. Fu, M., Gao, Y., Zhou, Q., Zhang, Q., Peng, Y., Tian, K., Wang, J. & Zheng, X. (2014). Human cytomegalovirus latent infection alters the expression of cellular and viral microRNA. Gene 536, 272–278.
24. Gallaher, A. M., Das, S., Xiao, Z., Andresson, T., Kieffer-Kwon, P., Happel, C. & Ziegelbauer, J. (2013). Proteomic screening of human targets of viral microRNAs reveals functions associated with immune evasion and angiogenesis. PLoS Pathog 9, e1003584.
25. Goodrum, F., Caviness, K. & Zagallo, P. (2012). Human cytomegalo-virus persistence. Cell Microbiol 14, 644–655.
26. Gottwein, E., Mukherjee, N., Sachse, C., Frenzel, C., Majoros, W. H., Chi, J. T., Braich, R., Manoharan, M., Soutschek, J. & other authors (2007). A viral microRNA functions as an orthologue of cellular miR-155. Nature 450, 1096–1099.
27. Gottwein, E., Corcoran, D. L., Mukherjee, N., Skalsky, R. L., Hafner, M., Nusbaum, J. D., Shamulailatpam, P., Love, C. L., Dave, S. S. & other authors (2011). Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines. Cell Host Microbe 10, 515–526.
28. Grey, F., Antoniewicz, A., Allen, E., Saugstad, J., McShea, A., Carrington, J. C. & Nelson, J. (2005). Identification and character¬ization of human cytomegalovirus-encoded microRNAs. J Virol 79, 12095–12099.
29. Grey, F., Meyers, H., White, E. A., Spector, D. H. & Nelson, J. (2007). A human cytomegalovirus-encoded microRNA regulates expression of multiple viral genes involved in replication. PLoS Pathog 3, e163.
30. Grosswendt, S., Filipchyk, A., Manzano, M., Klironomos, F., Schilling, M., Herzog, M., Gottwein, E. & Rajewsky, N. (2014). Unambiguous identification of miRNA:target site interactions by different types of ligation reactions. Mol Cell 54, 1042–1054.
31. Grundhoff, A. & Sullivan, C. S. (2011). Virus-encoded microRNAs. Virology 411, 325–343.
32. Haecker, I., Gay, L. A., Yang, Y., Hu, J., Morse, A. M., McIntyre, L. M. & Renne, R. (2012). Ago HITS-CLIP expands understanding of Kaposi’s sarcoma-associated herpesvirus miRNA function in primary effusion lymphomas. PLoS Pathog 8, e1002884.
33. Hancock, M. H., Tirabassi, R. S. & Nelson, J. A. (2012). Rhesus cytomegalovirus encodes seventeen microRNAs that are differentially expressed in vitro and in vivo. Virology 425, 133–142.
34. Helwak, A., Kudla, G., Dudnakova, T. & Tollervey, D. (2013). Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell 153, 654–665.
35. Hook, L., Hancock, M., Landais, I., Grabski, R., Britt, W. & Nelson, J. A. (2014a). Cytomegalovirus microRNAs. Curr Opin Virol 7, 40–46.
36. Hook, L. M., Grey, F., Grabski, R., Tirabassi, R., Doyle, T., Hancock, M., Landais, I., Jeng, S., McWeeney, S. & other authors (2014b). Cytomegalovirus miRNAs target secretory pathway genes to facilitate formation of the virion assembly compartment and reduce cytokine secretion. Cell Host Microbe 15, 363–373.
37. Jones, T., Ye, F., Bedolla, R., Huang, Y., Meng, J., Qian, L., Pan, H., Zhou, F., Moody, R. & other authors (2012). Direct and efficient cellular transformation of primary rat mesenchymal precursor cells by KSHV. J Clin Invest 122, 1076–1081.
38. Jung, Y. J., Choi, H., Kim, H. & Lee, S. K. (2014). MicroRNA miR-BART20-5p stabilizes Epstein–Barr virus latency by directly targeting BZLF1 and BRLF1. J Virol 88, 9027–9037.
39. Kim, S., Lee, S., Shin, J., Kim, Y., Evnouchidou, I., Kim, D., Kim, Y. K., Kim, Y. E., Ahn, J. H. & other authors (2011). Human cytomegalovirus microRNA miR-US4-1 inhibits CD8+ T cell responses by targeting the aminopeptidase ERAP1. Nat Immunol 12, 984–991.
40. Kim, Y., Lee, S., Kim, S., Kim, D., Ahn, J. H. & Ahn, K. (2012). Human cytomegalovirus clinical strain-specific microRNA miR-UL148D targets the human chemokine RANTES during infection. PLoS Pathog 8, e1002577.
41. Kincaid, R. P., Burke, J. M., Cox, J. C., de Villiers, E. M. & Sullivan, C. S. (2013). A human torque teno virus encodes a microRNA that inhibits interferon signaling. PLoS Pathog 9, e1003818.
42. Kozomara, A. & Griffiths-Jones, S. (2014). miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res 42 (Database issue), D68–D73.
43. Kramer, M. F., Jurak, I., Pesola, J. M., Boissel, S., Knipe, D. M. & Coen, D. M. (2011). Herpes simplex virus 1 microRNAs expressed abundantly during latent infection are not essential for latency in mouse trigeminal ganglia. Virology 417, 239–247.
44. Lee, S. H., Kalejta, R. F., Kerry, J., Semmes, O. J., O’Connor, C. M., Khan, Z., Garcia, B. A., Shenk, T. & Murphy, E. (2012). BclAF1 restriction factor is neutralized by proteasomal degradation and microRNA repression during human cytomegalovirus infection. Proc Natl Acad Sci U S A 109, 9575–9580.
45. Lee, S., Song, J., Kim, S., Kim, J., Hong, Y., Kim, Y., Kim, D., Baek, D. & Ahn, K. (2013). Selective degradation of host microRNAs by an intergenic HCMV noncoding RNA accelerates virus production. Cell Host Microbe 13, 678–690.
46. Lei, X., Bai, Z., Ye, F., Xie, J., Kim, C. G., Huang, Y. & Gao, S. J. (2010). Regulation of NF-kappaB inhibitor IkappaBalpha and viral replica-tion by a KSHV microRNA. Nat Cell Biol 12, 193–199.
47. Libri, V., Helwak, A., Miesen, P., Santhakumar, D., Borger, J. G., Kudla, G., Grey, F., Tollervey, D. & Buck, A. H. (2012). Murine cytomegalovirus encodes a miR-27 inhibitor disguised as a target. Proc Natl Acad Sci U S A 109, 279–284.
48. Lin, Z., Wang, X., Fewell, C., Cameron, J., Yin, Q. & Flemington, E. K. (2010). Differential expression of the miR-200 family microRNAs in epithelial and B cells and regulation of Epstein–Barr virus reactivation by the miR-200 family member miR-429. J Virol 84, 7892–7897.
49. Lin, X., Liang, D., He, Z., Deng, Q., Robertson, E. S. & Lan, K. (2011). miR-K12-7-5p encoded by Kaposi’s sarcoma-associated herpesvirus stabilizes the latent state by targeting viral ORF50/RTA. PLoS One 6, e16224.
50. Linnstaedt, S. D., Gottwein, E., Skalsky, R. L., Luftig, M. A. & Cullen, B. R. (2010). Virally induced cellular microRNA miR-155 plays a key role in B-cell immortalization by Epstein–Barr virus. J Virol 84, 11670–11678.
51. Lu, F., Weidmer, A., Liu, C. G., Volinia, S., Croce, C. M. & Lieberman, P. M. (2008). Epstein–Barr virus-induced miR-155 attenuates NF-kappaB signaling and stabilizes latent virus persistence. J Virol 82, 10436–10443.
52. Lu, C. C., Li, Z., Chu, C. Y., Feng, J., Feng, J., Sun, R. & Rana, T. M. (2010a). MicroRNAs encoded by Kaposi’s sarcoma-associated herpesvirus regulate viral life cycle. EMBO Rep 11, 784–790.
53. Lu, F., Stedman, W., Yousef, M., Renne, R. & Lieberman, P. M. (2010b). Epigenetic regulation of Kaposi’s sarcoma-associated herpesvirus latency by virus-encoded microRNAs that target Rta and the cellular Rbl2–DNMT pathway. J Virol 84, 2697–2706.
54. Marcinowski, L., Tanguy, M., Krmpotic, A., Rädle, B., Lisnić, V. J., Tuddenham, L., Chane-Woon-Ming, B., Ruzsics, Z., Erhard, F. & other authors (2012). Degradation of cellular mir-27 by a novel, highly abundant viral transcript is important for efficient virus replication in vivo. PLoS Pathog 8, e1002510.
55. Meyer, C., Grey, F., Kreklywich, C. N., Andoh, T. F., Tirabassi, R. S., Orloff, S. L. & Streblow, D. N. (2011). Cytomegalovirus microRNA expression is tissue specific and is associated with persistence. J Virol 85, 378–389.
56. Moody, R., Zhu, Y., Huang, Y., Cui, X., Jones, T., Bedolla, R., Lei, X., Bai, Z. & Gao, S. J. (2013). KSHV microRNAs mediate cellular transformation and tumorigenesis by redundantly targeting cell growth and survival pathways. PLoS Pathog 9, e1003857.
57. Murphy, E., Vańicek, J., Robins, H., Shenk, T. & Levine, A. J. (2008). Suppression of immediate-early viral gene expression by herpesvirus-coded microRNAs: implications for latency. Proc Natl Acad Sci U S A 105, 5453–5458.
58. Nachmani, D., Stern-Ginossar, N., Sarid, R. & Mandelboim, O. (2009). Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells. Cell Host Microbe 5, 376–385.
59. Noriega, V., Redmann, V., Gardner, T. & Tortorella, D. (2012). Diverse immune evasion strategies by human cytomegalovirus. Immunol Res 54, 140–151.
60. O’Connor, C. M., Vanicek, J. & Murphy, E. A. (2014). Host microRNA regulation of human cytomegalovirus immediate early protein translation promotes viral latency. J Virol 88, 5524–5532.
61. Pan, D., Flores, O., Umbach, J. L., Pesola, J. M., Bentley, P., Rosato, P. C., Leib, D. A., Cullen, B. R. & Coen, D. M. (2014). A neuron-specific host microRNA targets herpes simplex virus-1 ICP0 expression and promotes latency. Cell Host Microbe 15, 446–456.
62. Parnas, O., Corcoran, D. L. & Cullen, B. R. (2014). Analysis of the mRNA targetome of microRNAs expressed by Marek’s disease virus. MBio 5, e01060-13.
63. Pavelin, J., Reynolds, N., Chiweshe, S., Wu, G., Tiribassi, R. & Grey, F. (2013). Systematic microRNA analysis identifies ATP6V0C as an essential host factor for human cytomegalovirus replication. PLoS Pathog 9, e1003820.
64. Pellet, E. R. & Roizman, B. (2013). Herpesviridae. In Fields Virology, 6th edn, pp. 1803–1822. Edited by D. M. Knipe & P. M. Howley. Philadelphia, PA: Wolters Kluwer/Lippincott Williams & Wilkins.
65. Pfeffer, S., Sewer, A., Lagos-Quintana, M., Sheridan, R., Sander, C., Grässer, F. A., van Dyk, L. F., Ho, C. K., Shuman, S. & other authors (2005). Identification of microRNAs of the herpesvirus family. Nat Methods 2, 269–276.
66. Poole, E., McGregor Dallas, S. R., Colston, J., Joseph, R. S. & Sinclair, J. (2011). Virally induced changes in cellular microRNAs maintain latency of human cytomegalovirus in CD34+ progenitors. J Gen Virol 92, 1539–1549.
67. Qiu, J. & Thorley-Lawson, D. A. (2014). EBV microRNA BART 18-5p targets MAP3K2 to facilitate persistence in vivo by inhibiting viral replication in B cells. Proc Natl Acad Sci U S A 111, 11157–11162.
68. Riaz, A., Dry, I., Levy, C. S., Hopkins, J., Grey, F., Shaw, D. J. & Dalziel, R. G. (2014). Ovine herpesvirus-2-encoded microRNAs target virus genes involved in virus latency. J Gen Virol 95, 472–480.
69. Riley, K. J., Rabinowitz, G. S., Yario, T. A., Luna, J. M., Darnell, R. B. & Steitz, J. A. (2012). EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency. EMBO J 31, 2207–2221.
70. Rodriguez, A., Vigorito, E., Clare, S., Warren, M. V., Couttet, P., Soond, D. R., van Dongen, S., Grocock, R. J., Das, P. P. & other authors (2007). Requirement of bic/microRNA-155 for normal immune function. Science 316, 608–611.
71. Roizman, B. & Whitley, R. J. (2013). An inquiry into the molecular basis of HSV latency and reactivation. Annu Rev Microbiol 67, 355–374.
72. Seto, E., Moosmann, A., Grömminger, S., Walz, N., Grundhoff, A. & Hammerschmidt, W. (2010). Micro RNAs of Epstein–Barr virus promote cell cycle progression and prevent apoptosis of primary human B cells. PLoS Pathog 6, e1001063.
73. Shen, Z. Z., Pan, X., Miao, L. F., Ye, H. Q., Chavanas, S., Davrinche, C., McVoy, M. & Luo, M. H. (2014). Comprehensive analysis of human cytomegalovirus microRNA expression during lytic and quiescent infection. PLoS One 9, e88531.
74. Sin, S. H., Kim, Y. B. & Dittmer, D. P. (2013). Latency locus complements microRNA 155 deficiency in vivo. J Virol 87, 11908–11911.
75. Sinclair, J. H. & Reeves, M. B. (2013). Human cytomegalovirus manipulation of latently infected cells. Viruses 5, 2803–2824.
76. Skalsky, R. L., Samols, M. A., Plaisance, K. B., Boss, I. W., Riva, A., Lopez, M. C., Baker, H. V. & Renne, R. (2007). Kaposi’s sarcoma-associated herpesvirus encodes an ortholog of miR-155. J Virol 81, 12836–12845.
77. Skalsky, R. L., Corcoran, D. L., Gottwein, E., Frank, C. L., Kang, D., Hafner, M., Nusbaum, J. D., Feederle, R., Delecluse, H. J. & other authors (2012). The viral and cellular microRNA targetome in lymphoblastoid cell lines. PLoS Pathog 8, e1002484.
78. Smith, M. S., Goldman, D. C., Bailey, A. S., Pfaffle, D. L., Kreklywich, C. N., Spencer, D. B., Othieno, F. A., Streblow, D. N., Garcia, J. V. & other authors (2010). Granulocyte-colony stimulating factor reacti¬vates human cytomegalovirus in a latently infected humanized mouse model. Cell Host Microbe 8, 284–291.
79. Stark, T. J., Arnold, J. D., Spector, D. H. & Yeo, G. W. (2012). High-resolution profiling and analysis of viral and host small RNAs during human cytomegalovirus infection. J Virol 86, 226–235.
80. Stern-Ginossar, N., Elefant, N., Zimmermann, A., Wolf, D. G., Saleh, N., Biton, M., Horwitz, E., Prokocimer, Z., Prichard, M. & other authors (2007). Host immune system gene targeting by a viral miRNA. Science 317, 376–381.
81. Suffert, G., Malterer, G., Hausser, J., Viiliäinen, J., Fender, A., Contrant, M., Ivacevic, T., Benes, V., Gros, F. & other authors (2011). Kaposi’s sarcoma herpesvirus microRNAs target caspase 3 and regulate apoptosis. PLoS Pathog 7, e1002405.
82. Sunil-Chandra, N. P., Efstathiou, S. & Nash, A. A. (1992). Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo. J Gen Virol 73, 3275–3279.
83. Sunil-Chandra, N. P., Arno, J., Fazakerley, J. & Nash, A. A. (1994). Lymphoproliferative disease in mice infected with murine gamma-herpesvirus 68. Am J Pathol 145, 818–826.
84. Tang, S., Bertke, A. S., Patel, A., Wang, K., Cohen, J. I. & Krause, P. R. (2008). An acutely and latently expressed herpes simplex virus 2 viral microRNA inhibits expression of ICP34.5, a viral neurovirulence factor. Proc Natl Acad Sci U S A 105, 10931–10936.
85. Tang, S., Patel, A. & Krause, P. R. (2009). Novel less-abundant viral microRNAs encoded by herpes simplex virus 2 latency-associated transcript and their roles in regulating ICP34.5 and ICP0 mRNAs. J Virol 83, 1433–1442.
86. Tang, S., Bertke, A. S., Patel, A., Margolis, T. P. & Krause, P. R. (2011). Herpes simplex virus 2 microRNA miR-H6 is a novel latency-associated transcript-associated microRNA, but reduction of its expression does not influence the establishment of viral latency or the recurrence phenotype. J Virol 85, 4501–4509.
87. Tarrant-Elorza, M., Rossetto, C. C. & Pari, G. S. (2014). Maintenance and replication of the human cytomegalovirus genome during latency. Cell Host Microbe 16, 43–54.
88. Umbach, J. L., Kramer, M. F., Jurak, I., Karnowski, H. W., Coen, D. M. & Cullen, B. R. (2008). MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs. Nature 454, 780–783.
89. Umbach, J. L., Nagel, M. A., Cohrs, R. J., Gilden, D. H. & Cullen, B. R. (2009). Analysis of human alphaherpesvirus microRNA expression in latently infected human trigeminal ganglia. J Virol 83, 10677–10683.
90. Umbach, J. L., Wang, K., Tang, S., Krause, P. R., Mont, E. K., Cohen, J. I. & Cullen, B. R. (2010). Identification of viral microRNAs expressed in human sacral ganglia latently infected with herpes simplex virus 2. J Virol 84, 1189–1192.
91. Vereide, D. T., Seto, E., Chiu, Y. F., Hayes, M., Tagawa, T., Grundhoff, A., Hammerschmidt, W. & Sugden, B. (2014). Epstein–Barr virus maintains lymphomas via its miRNAs. Oncogene 33, 1258–1264.
92. Wahl, A., Linnstaedt, S. D., Esoda, C., Krisko, J. F., Martinez-Torres, F., Delecluse, H. J., Cullen, B. R. & Garcia, J. V. (2013). A cluster of virus-encoded microRNAs accelerates acute systemic Epstein–Barr virus infection but does not significantly enhance virus-induced oncogenesis in vivo. J Virol 87, 5437–5446.
93. Xia, T., O’Hara, A., Araujo, I., Barreto, J., Carvalho, E., Sapucaia, J. B., Ramos, J. C., Luz, E., Pedroso, C. & other authors (2008). EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3. Cancer Res 68, 1436–1442.
94. Ye, F. C., Zhou, F. C., Xie, J. P., Kang, T., Greene, W., Kuhne, K., Lei, X. F., Li, Q. H. & Gao, S. J. (2008). Kaposi’s sarcoma-associated herpesvirus latent gene vFLIP inhibits viral lytic replication through NF-kappaB-mediated suppression of the AP-1 pathway: a novel mechanism of virus control of latency. J Virol 82, 4235–4249.
95. Yin, Q., McBride, J., Fewell, C., Lacey, M., Wang, X., Lin, Z., Cameron, J. & Flemington, E. K. (2008). MicroRNA-155 is an Epstein–Barr virus-induced gene that modulates Epstein–Barr virus-regulated gene expression pathways. J Virol 82, 5295–5306.
96. Yin, Q., Wang, X., Fewell, C., Cameron, J., Zhu, H., Baddoo, M., Lin, Z. & Flemington, E. K. (2010). MicroRNA miR-155 inhibits bone morphogenetic protein (BMP) signaling and BMP-mediated Epstein–Barr virus reactivation. J Virol 84, 6318–6327.
97. Zhao, Y., Xu, H., Yao, Y., Smith, L. P., Kgosana, L., Green, J., Petherbridge, L., Baigent, S. J. & Nair, V. (2011). Critical role of the virus-encoded microRNA-155 ortholog in the induction of Marek’s disease lymphomas. PLoS Pathog 7, e1001305.
98. Zhu, J. Y., Strehle, M., Frohn, A., Kremmer, E., Höfig, K. P., Meister, G. & Adler, H. (2010). Identification and analysis of expression of novel microRNAs of murine gammaherpesvirus 68. J Virol 84, 10266–10275.
99. Ziegelbauer, J. M., Sullivan, C. S. & Ganem, D. (2009). Tandem array-based expression screens identify host mRNA targets of virus-encoded microRNAs. Nat Genet 41, 130–134.